免疫蛋白診斷檢測市場規模、佔有率和成長分析（按檢測方法、應用、技術、最終用途、分銷管道和地區分類）－2026-2033年產業預測

預計到 2024 年，免疫蛋白診斷測試市場規模將達到 96.1 億美元，到 2025 年將達到 103 億美元，到 2033 年將達到 179.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.2%。

由於感染疾病和慢性病的增加以及人們對早期檢測意識的提高，免疫蛋白診斷檢測市場正經歷顯著成長。酵素免疫分析法(ELISA) 和化學冷光免疫檢測等診斷技術的創新提高了基於蛋白質的診斷的準確性和效率。人口老化加劇和醫療費用支出不斷成長也是推動市場擴張的因素。然而，預算限制和嚴格的法規結構等潛在挑戰可能會阻礙市場成長。儘管如此，對可靠、快速的診斷解決方案的強勁需求（這些解決方案對於有效的疾病管理和明智的治療決策至關重要）是整體趨勢的核心，並推動市場在醫療保健領域持續發展。

免疫蛋白診斷檢測市場成長要素

免疫蛋白診斷測試市場成長的主要促進因素是感染疾病、自體免疫疾病和感染疾病等多種健康問題至關重要。此外，人們對早期診斷重要性的認知不斷提高，以及診斷技術的進步，也推動了對這些測試的需求。該領域認知的不斷提高和創新正在促進免疫蛋白診斷測試行業的擴張。

免疫蛋白診斷檢測市場的限制因素

免疫蛋白診斷檢測市場面臨的主要限制因素是這些診斷檢測的開發和實施過程複雜且高成本。建構可靠且特異性的檢測方法需要大量的研究、開發和檢驗工作，這會耗費大量時間和資源。此外，這些檢測的成本和可近性在資源有限的醫療機構中構成障礙，難以廣泛應用。這種情況可能會限制檢測的普及，並最終阻礙市場成長潛力。因此，這些挑戰持續影響著整個產業的進步和發展。

免疫蛋白診斷測試市場趨勢

免疫蛋白診斷檢測市場呈現顯著成長趨勢，這主要得益於感染疾病和慢性病發病率上升，導致對精準診斷解決方案的需求激增。多重免疫檢測平台和就地檢驗（POC​​T）等技術創新能夠提供更快、更精確的檢測結果，進而提高臨床決策的準確性。此外，對個人化醫療和生物標記研究的日益重視也促進了這些診斷檢測的廣泛應用。同時，相關人員和研究機構之間的策略合作正在推動創新，並支持調查方法的進步，最終推動整個免疫蛋白診斷領域的擴張。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球免疫蛋白質診斷檢測市場規模（按檢測類型和複合年成長率分類）（2026-2033 年）

• 補體系統蛋白診斷測試
• 遊離輕鏈診斷測試
• 肝珠蛋白診斷測試
• 免疫球蛋白診斷試驗
• 前白蛋白診斷試驗
• C反應蛋白（CRP）診斷試驗

全球免疫蛋白質診斷檢測市場規模（按應用領域及複合年成長率分類）（2026-2033 年）

• 傳染病檢查
• 腫瘤檢測
• 內分泌檢查
• 毒理學測試
• 過敏測試
• 自體免疫疾病檢測

全球免疫蛋白質診斷檢測市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 免疫測量
• 酵素免疫分析法
• 化學冷光法
• 螢光
• 免疫比濁法
• 免疫蛋白電泳

全球免疫蛋白質診斷檢測市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院和診所
• 診斷檢查室
• 其他

全球免疫蛋白診斷檢測市場規模（依通路分類）及複合年成長率（2026-2033 年）

• 直接競標
• 零售

全球免疫蛋白診斷檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

結論與建議

Immunoprotein Diagnostic Testing Market size was valued at USD 9.61 Billion in 2024 and is poised to grow from USD 10.3 Billion in 2025 to USD 17.96 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The immunoprotein diagnostic testing market is experiencing considerable growth, fueled by the rise in infectious and chronic diseases and heightened awareness surrounding early detection. Innovations in diagnostic technologies, like enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays, have enhanced the precision and efficiency of protein-based diagnostics. The expanding elderly population and increased healthcare spending are additional factors contributing to market expansion. However, potential challenges such as budget limitations and strict regulatory frameworks may hinder growth. Nevertheless, the overarching trend centers on the strong demand for reliable and swift diagnostic solutions, essential for effective disease management and informed therapeutic decisions, positioning the market for continued progression in the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoprotein Diagnostic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunoprotein Diagnostic Testing Market Segments Analysis

Global Immunoprotein Diagnostic Testing Market is segmented by test, application, technology, end use, distribution channel and region. Based on test, the market is segmented into complement system proteins diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests andc-reactive protein (CRP) diagnostic tests. Based on application, the market is segmented into infectious disease testing, oncology testing, endocrine testing, toxicology testing, allergy testing and autoimmune disease testing. Based on technology, the market is segmented into radioimmunoassay, enzyme based immunoassay, chemiluminescence assay, immunofluorescence assay, immunoturbidity assay and immunoprotein electrophoresis. Based on end use, the market is segmented into hospitals and clinics, diagnostic laboratories and others. Based on distribution channel, the market is segmented into direct tender and retail sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Immunoprotein Diagnostic Testing Market

A key factor influencing the growth of the immunoprotein diagnostic testing market is the rising incidence of both infectious and chronic illnesses, which significantly heightens the need for precise and prompt diagnostic solutions. Immunoprotein assays are essential for detecting various health issues, including cancers, autoimmune diseases, and infections. Additionally, the growing recognition of the importance of early diagnosis, combined with advancements in diagnostic technology, is driving the demand for these tests. This heightened awareness and innovation in the field are collectively contributing to the expansion of the immunoprotein diagnostic testing sector.

Restraints in the Immunoprotein Diagnostic Testing Market

A major limitation affecting the Immunoprotein Diagnostic Testing market is the intricate and expensive nature of creating and executing these diagnostic tests. Crafting reliable and specific tests demands extensive research, development, and validation efforts, which can be both time-consuming and resource-heavy. Additionally, the cost and availability of these tests present obstacles in healthcare environments with limited resources, making it difficult for them to gain widespread acceptance. This situation could restrict their adoption and ultimately inhibit the growth potential of the market. Consequently, these challenges continue to impact the overall progress and expansion of the industry.

Market Trends of the Immunoprotein Diagnostic Testing Market

The immunoprotein diagnostic testing market is experiencing notable growth trends driven by a surge in the need for accurate diagnostic solutions amid rising infectious and chronic disease rates. Innovations in technology, including multiplex immunoassay platforms and point-of-care testing, are facilitating quicker and more precise outcomes, enhancing clinical decision-making. The increasing emphasis on personalized medicine and biomarker research is also contributing to the widespread adoption of these diagnostic tests. Furthermore, strategic collaborations between industry stakeholders and research entities are fostering innovation, propelling advancements in testing methodologies, and ultimately driving the overall expansion of the immunoprotein diagnostic landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Immunoprotein Diagnostic Testing Market Size by Test & CAGR (2026-2033)

• Market Overview
• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Immunoglobulin Diagnostic Tests
• Prealbumin Diagnostic Tests
• C-Reactive Protein (Crp) Diagnostic Tests

Global Immunoprotein Diagnostic Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Endocrine Testing
• Toxicology Testing
• Allergy Testing
• Autoimmune Disease Testing

Global Immunoprotein Diagnostic Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Radioimmunoassay
• Enzyme Based Immunoassay
• Chemiluminescence Assay
• Immunofluorescence Assay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis

Global Immunoprotein Diagnostic Testing Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals And Clinics
• Diagnostic Laboratories
• Others

Global Immunoprotein Diagnostic Testing Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Tender
• Retail Sales

Global Immunoprotein Diagnostic Testing Market Size & CAGR (2026-2033)

• North America (Test, Application, Technology, End Use, Distribution Channel)
  • USA
  • Canada
• Europe (Test, Application, Technology, End Use, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test, Application, Technology, End Use, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test, Application, Technology, End Use, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test, Application, Technology, End Use, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations